Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3257 | 2027 | 27.4 | 57% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
11 | 3 | ATRIAL FIBRILLATION//CARDIAC & CARDIOVASCULAR SYSTEM//CATHETER ABLATION | 130936 |
822 | 2 | CALCIUM ANTAGONISTS//CALCIUM CHANNEL BLOCKERS//NIFEDIPINE | 11902 |
3257 | 1 | ISRADIPINE//FELODIPINE//JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 2027 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ISRADIPINE | authKW | 251356 | 4% | 23% | 74 |
2 | FELODIPINE | authKW | 172046 | 3% | 19% | 60 |
3 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | journal | 142340 | 16% | 3% | 322 |
4 | CALCIUM ANTAGONISTS | authKW | 72010 | 4% | 5% | 89 |
5 | CAS 75695 93 1 | authKW | 62759 | 0% | 83% | 5 |
6 | FELODIPINE ER | authKW | 46121 | 0% | 44% | 7 |
7 | NORMOTENSIVE VOLUNTEERS | authKW | 45188 | 0% | 100% | 3 |
8 | NITRENDIPINE | authKW | 31282 | 1% | 8% | 26 |
9 | DILTIAZEM ER | authKW | 30125 | 0% | 100% | 2 |
10 | DILTIAZEM ONCE DAILY | authKW | 30125 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 16426 | 52% | 0% | 1061 |
2 | Cardiac & Cardiovascular System | 12621 | 31% | 0% | 637 |
3 | Peripheral Vascular Diseases | 4942 | 15% | 0% | 304 |
4 | Medicine, General & Internal | 1244 | 13% | 0% | 260 |
5 | Medicine, Research & Experimental | 645 | 8% | 0% | 157 |
6 | Toxicology | 340 | 5% | 0% | 94 |
7 | Urology & Nephrology | 119 | 3% | 0% | 61 |
8 | Geriatrics & Gerontology | 40 | 1% | 0% | 21 |
9 | Physiology | 33 | 2% | 0% | 50 |
10 | Chemistry, Medicinal | 26 | 2% | 0% | 38 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CHIM JUSTICE | 15063 | 0% | 100% | 1 |
2 | DIPARTIMENTO CLIN MED INTERNE | 15063 | 0% | 100% | 1 |
3 | GODECKE AG | 15063 | 0% | 100% | 1 |
4 | HYPERTENS CLIN PHARMACOL SECT | 15063 | 0% | 100% | 1 |
5 | HYPERTENS CLIN PHARMACOL UNIT | 15063 | 0% | 100% | 1 |
6 | HYPERTENS DIS SECT INTERNAL MED | 15063 | 0% | 100% | 1 |
7 | MED 545 | 15063 | 0% | 100% | 1 |
8 | MED AVE BURGOS 91 | 15063 | 0% | 100% | 1 |
9 | MED OFICINA EDUC MED | 15063 | 0% | 100% | 1 |
10 | MED PHARMACOL GIVEN BLDG | 15063 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 142340 | 16% | 3% | 322 |
2 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 26536 | 5% | 2% | 92 |
3 | DRUGS | 17109 | 4% | 1% | 80 |
4 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 14586 | 4% | 1% | 83 |
5 | JOURNAL OF HYPERTENSION | 9391 | 4% | 1% | 78 |
6 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 8002 | 3% | 1% | 66 |
7 | AMERICAN JOURNAL OF HYPERTENSION | 7371 | 3% | 1% | 54 |
8 | CARDIOVASCULAR DRUGS AND THERAPY | 6951 | 1% | 2% | 30 |
9 | GERIATRIC CARDIOVASCULAR MEDICINE | 5889 | 0% | 13% | 3 |
10 | AMERICAN JOURNAL OF CARDIOLOGY | 5885 | 5% | 0% | 103 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ISRADIPINE | 251356 | 4% | 23% | 74 | Search ISRADIPINE | Search ISRADIPINE |
2 | FELODIPINE | 172046 | 3% | 19% | 60 | Search FELODIPINE | Search FELODIPINE |
3 | CALCIUM ANTAGONISTS | 72010 | 4% | 5% | 89 | Search CALCIUM+ANTAGONISTS | Search CALCIUM+ANTAGONISTS |
4 | CAS 75695 93 1 | 62759 | 0% | 83% | 5 | Search CAS+75695+93+1 | Search CAS+75695+93+1 |
5 | FELODIPINE ER | 46121 | 0% | 44% | 7 | Search FELODIPINE+ER | Search FELODIPINE+ER |
6 | NORMOTENSIVE VOLUNTEERS | 45188 | 0% | 100% | 3 | Search NORMOTENSIVE+VOLUNTEERS | Search NORMOTENSIVE+VOLUNTEERS |
7 | NITRENDIPINE | 31282 | 1% | 8% | 26 | Search NITRENDIPINE | Search NITRENDIPINE |
8 | DILTIAZEM ER | 30125 | 0% | 100% | 2 | Search DILTIAZEM+ER | Search DILTIAZEM+ER |
9 | DILTIAZEM ONCE DAILY | 30125 | 0% | 100% | 2 | Search DILTIAZEM+ONCE+DAILY | Search DILTIAZEM+ONCE+DAILY |
10 | LOMIR SROR | 30125 | 0% | 100% | 2 | Search LOMIR+SROR | Search LOMIR+SROR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | TODD, PA , FAULDS, D , (1992) FELODIPINE - A REVIEW OF THE PHARMACOLOGY AND THERAPEUTIC USE OF THE EXTENDED RELEASE FORMULATION IN CARDIOVASCULAR DISORDERS.DRUGS. VOL. 44. ISSUE 2. P. 251-277 | 75 | 77% | 62 |
2 | FRISHMAN, WH , STROH, JA , GREENBERG, S , SUAREZ, T , KARP, A , PELED, H , (1988) CALCIUM-CHANNEL BLOCKERS IN SYSTEMIC HYPERTENSION.MEDICAL CLINICS OF NORTH AMERICA. VOL. 72. ISSUE 2. P. 449-499 | 82 | 64% | 21 |
3 | SALTIEL, E , ELLRODT, AG , MONK, JP , LANGLEY, MS , (1988) FELODIPINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN HYPERTENSION.DRUGS. VOL. 36. ISSUE 4. P. 387-428 | 75 | 64% | 79 |
4 | ELVELIN, L , KENNERFALK, A , ELMFELDT, D , (1993) TOLERABILITY AND SAFETY OF FELODIPINE.CARDIOVASCULAR DRUG REVIEWS. VOL. 11. ISSUE 1. P. 126-147 | 56 | 67% | 5 |
5 | BROGDEN, RN , SORKIN, EM , (1995) ISRADIPINE - AN UPDATE OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY IN THE TREATMENT OF MILD-TO-MODERATE HYPERTENSION.DRUGS. VOL. 49. ISSUE 4. P. 618-649 | 67 | 48% | 26 |
6 | CUMMINGS, DM , AMADIO, P , NELSON, L , FITZGERALD, JM , (1991) THE ROLE OF CALCIUM-CHANNEL BLOCKERS IN THE TREATMENT OF ESSENTIAL-HYPERTENSION.ARCHIVES OF INTERNAL MEDICINE. VOL. 151. ISSUE 2. P. 250-259 | 71 | 54% | 25 |
7 | FITTON, A , BENFIELD, P , (1990) ISRADIPINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN CARDIOVASCULAR-DISEASE.DRUGS. VOL. 40. ISSUE 1. P. 31-74 | 72 | 50% | 90 |
8 | FRISHMAN, WH , STROH, JA , GREENBERG, SM , SUAREZ, T , KARP, A , PELED, HB , (1987) CALCIUM-CHANNEL BLOCKERS IN SYSTEMIC HYPERTENSION.CURRENT PROBLEMS IN CARDIOLOGY. VOL. 12. ISSUE 5. P. 285-346 | 73 | 61% | 3 |
9 | ZING, W , FERGUSON, RK , VLASSES, PH , (1991) CALCIUM-ANTAGONISTS IN ELDERLY AND BLACK HYPERTENSIVE PATIENTS - THERAPEUTIC CONTROVERSIES.ARCHIVES OF INTERNAL MEDICINE. VOL. 151. ISSUE 11. P. 2154-2162 | 38 | 90% | 23 |
10 | DUNSELMAN, PHJM , EDGAR, B , (1991) FELODIPINE CLINICAL PHARMACOKINETICS.CLINICAL PHARMACOKINETICS. VOL. 21. ISSUE 6. P. 418-430 | 42 | 78% | 36 |
Classes with closest relation at Level 1 |